SUPPORTING STATEMENT
U.S. Department of Commerce
National Institute of Standards and Technology
iEdison
OMB Control No. 0693-0090
SUPPORTING STATEMENT PART A
Abstract
Patent Rights in Inventions Made with Federal Assistance, commonly referred to as “The Bayh-Dole Act” (35 USC § 200-212) and its implementing regulations (37 CFR 401) allow for recipients of federal research funding (Contractors) to retain ownership of inventions developed under federal funding agreements. In exchange, the government retains certain rights to the invention, including a world-wide right to use by or on behalf of the U.S. government. The law also requires the Contractor to obtain permission for certain actions and fulfill reporting requirements including:
Initial reporting of invention;
Decision to retain title to invention;
Filing of patent protection;
Evidence of government support clause within patents;
Submission of a license confirming the government’s rights;
Notice if the Contractor is going to discontinue the pursuit or continuance of patent protection;
Information related to the development and utilization of invention;
Permission to assign to a third party; and
Permission to waive domestic manufacturing requirements.
This information is used for a variety of reasons. It allows the government to identify technologies to which the government has rights to use without additional payment or licensing. This acts as a time and cost-saving mechanism to avoid unnecessary negotiating and payment. It also provides data for calculation of return on investment (ROI) from federal funding and identifies successful research programs. Thirdly, it allows the government the opportunity to timely protect inventions which the Contractor declines title or discontinues patent protection.
Historically, NIH has collected this information via their on-line portal, iEdison. Although previously administered by NIH, NIST will take on these duties in the future. Agencies that do not register with iEdison are required to collect this information independently.
Justification
1. Explain the circumstances that make the collection of information necessary. Identify any legal or administrative requirements that necessitate the collection. Attach a copy of the appropriate section of each statute and regulation mandating or authorizing the collection of information.
The Bayh-Dole Act (35 USC § 200-212) and its implementing regulations (37 CFR 401) require Contractors to report information related to inventions and patents to the federal agency which awarded the relevant funding. The purpose of this legislation included promoting utilization of inventions resulting from federal R&D funding, encourage collaboration between non-profit and for-profit entities, increase commercialization and public availability of inventions made in the United States, and to ensure that the Government obtains sufficient rights in federally funded inventions to meet the needs of the Government and protect the public. To facilitate these and other objectives as well as to track both compliance with and effectiveness of this legislation, collection of data is required. Initially when the legislation was passed, this information had to be reported manually via mail or fax. In the mid-90s, the NIH developed the iEdison web-portal which allowed Contractors to electronically report this information. To minimize burden on both Contractors and agencies, the NIH allowed other agencies to register to use this system as well, and eventually more than 30 federal agencies were using this system instead of traditional mail, fax, or email submission. Recently, there was a mutual decision to transfer management and upkeep of the iEdison system and its associated data from NIH to NIST.
The collection of this information allows the federal government to:
Ensure compliance with Bayh-Dole Act reporting and timing requirements to ensure that federally funded inventions are protected in a timely manner in accordance with patent laws, that federally funded inventions are being commercially developed, and ensure that preference is giving to US industry and small businesses.
Determine return on investment (ROI) of taxpayer dollars used on extramural federal research programs.
Identify technologies to which the government has rights to avoid unnecessary licensing and fees.
2. Indicate how, by whom, and for what purpose the information is to be used. Except for a new collection, indicate the actual use the agency has made of the information received from the current collection.
The table below details the information/data fields being requested as well as the statute or regulation(s) authorizing the collection of this information and the needs or uses for collection of this piece of information. The information will be collected in one of three major record categories within iEdison: Invention, Patent, or Utilization Records. The majority of the information is already being collected by the current iEdison website hosted by the NIH. Any additional data fields and/or changes to data fields have been made to comply with updated regulations, to provide clarity, or at the justified request of federal agencies or Contractors who provide the information into the iEdison database. It should be noted that because the iEdison system is used by multiple agencies, the needs/uses listed represent the needs/uses for all agency iEdison users. If only certain agencies use or requested a particular piece of information, that is indicated within the chart. Because most of the information is not made public, but the Contractors who provide the information can use the iEdison database for their own reporting/tracking purposes, the Contractors own uses of the information are also included in the table below. Note on revisions: Utilization reports are due annually. If a user must submit a utilization report that was due before 2023 (applicant should have completed in a previous year but they are late), then the applicant will follow the Utilization Record outline in the below table. If an applicant submits a utilization report for 2023 or later, then they will follow the revised Utilization Records outlined in Question 15 of this supporting statement.
Item No. |
Record Type where Requirement is Located |
Requirement |
Statute |
Regulation |
Needs/Uses |
1 |
Invention Record |
Invention Docket Number |
|
|
|
2 |
Invention Record |
Invention Title |
|
|
|
3 |
Invention Record |
Inventor(s) (First, Middle, Last Name) |
|
37 CFR 401.14(c)(1) |
|
|
Invention Record |
Is this Inventor a US Federal Employee? |
|
37 CFR 401.10(a) |
|
|
Invention Record |
US Federal Agency |
|
37 CFR 401.10(a) |
|
5 |
Invention Record |
Date Invention Reported to Organization |
35 USC 202(c)(1) |
37 CFR 401.14(c)(1) |
|
6 |
Invention Record |
Primary Funding Agency |
|
37 CFR 401.13(a) |
|
7 |
Invention Record |
Funding Agency |
35 USC 202(c)(1) |
37 CFR 401.14(c)(1) |
|
8 |
Invention Record |
Funding Agreement Grant/Contract Number |
35 USC 202(c)(1) |
37 CFR 401.14(c)(1) |
|
|
Invention Record |
Start Date |
|
|
|
|
Invention Record |
Award Type |
|
|
|
|
Invention Record |
Agreement Type |
|
|
|
9 |
Invention Record |
Bayh-Dole Regulation Version Original/2018 |
|
|
|
10 |
Invention Record |
Subcontract Number |
|
|
|
11 |
Invention Record |
Prime Contractor Name |
|
|
|
12 |
Invention Record |
Prime Contractor UEI/DUNS |
|
|
|
13 |
Invention Record |
Prime Contractor City |
|
|
|
14 |
Invention Record |
Prime Contractor State |
|
|
|
15 |
Invention Record |
Prime Contractor Country |
|
|
|
16 |
Invention Record |
Budget and Reporting Code(s) |
|
|
|
|
Invention Record |
Is this invention made under a funding agreement subject to a determination of exceptional circumstances? (Y/N) |
|
|
|
17 |
Invention Record |
Title Election Status |
35 USC 202(c)(2) |
37 CFR 401.14(c)(2) |
|
18 |
Invention Record |
Does Not RetainTitle Reason |
|
|
|
|
Invention Record |
Does Not Retain Title Other Reason |
|
|
|
19 |
Invention Record |
Parent Invention Report Number |
N/A |
N/A |
|
20 |
Invention Record |
Date of First Publication/Sale/Public Use Date |
|
37 CFR 401.14(c)(1) |
|
21 |
Invention Record |
Organization Code for Other Organizations to View Invention and Related Patents |
|
|
|
22 |
Invention Record |
Requests – Request Type |
35 USC 202(c)(1-3); 35 USC 202(c)(7); 35 USC 204 |
37 CFR 401.14(c)(5); 37 CFR 401.14(k)(1); 37 CFR 401.14(i) |
|
|
Invention Record |
Requests – Assigning To |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Invention Record |
Requests – Inventor Name |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Invention Record |
Requests – Inventor’s Organization Code |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Invention Record |
Requests – Third Party Name |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Invention Record |
Requests – Third Party Organization Code |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Invention Record |
Requests – Transfer to Organization |
|
|
|
|
Invention Record |
Requests – Number of Months Extension |
|
|
|
23 |
Invention Record |
Requests – Support Document |
35 USC 202(c)(1-3); 35 USC 202(c)(7); 35 USC 204 |
37 CFR 401.14(c)(5); 37 CFR 401.14(k)(1); 37 CFR 401.14(i) |
|
24 |
Invention Record |
Request – Request Reasons/Comments |
35 USC 202(c)(6); 35 USC 202(c)(7); |
37 CFR 401.14(c)(5); 37 CFR 401.14(k)(1); |
|
|
Invention Record |
Request – Domestic Waiver Reason |
35 USC 204 |
37 CFR 401.14(i) |
|
25 |
Invention Record |
Keywords |
|
|
|
26 |
Invention Record |
Invention Disclosure Form File Upload |
|
37 CFR 401.14(c)(1) |
|
27 |
Invention Record |
Other Document Files |
|
|
|
28 |
Invention Record |
Explanatory Notes |
|
|
|
|
Invention Record |
Discussion Subject |
|
|
|
29 |
Invention Record |
Discussion Comments |
|
|
|
30 |
Patent Record |
Patent Docket Number |
|
|
|
31 |
Patent Record |
Patent Type |
|
|
|
32 |
Patent Record |
Patent Status |
|
37 CFR 401.14(f)(3) |
|
33 |
Patent Record |
Patent Title |
|
|
|
34 |
Patent Record |
Patent Inventor(s) (First, Middle, Last Name) |
|
|
|
35 |
Patent Record |
Patent Application Number (Provisional Application Number, PCT Application Number, Non-Provisional Application Number) |
|
37 CFR 401.5(f)(2) |
|
36 |
Patent Record |
Patent Application Filing Date (Provisional Application Date, PCT Application Date, Non-Provisional Application Date) |
35 USC 202(c)(3) |
37 CFR 401.14(c)(2) |
|
37 |
Patent Record |
Issued Patent Number |
|
37 CFR 401.5(f)(2) |
|
38 |
Patent Record |
Issued Patent Date |
|
37 CFR 401.5(f)(2) |
|
39 |
Patent Record |
Expiration Date |
|
|
|
|
Patent Record |
Organization Code for Other Organizations to View Patent |
|
|
|
41 |
Patent Record |
Parent Patent(s) |
|
|
|
43 |
Patent Record |
Foreign Filings (Country, Status, FilingDate) |
|
37 CFR 401.5(f)(2)/ 37 CFR 401.5(f)(2) |
|
|
Patent Record |
Confirmatory License Execution Date |
|
|
|
44 |
Patent Record |
Confirmatory License Document Upload |
|
37 CFR 401.14(f)(1) |
|
45 |
Patent Record |
Government Support Clause Document Upload |
35 USC 202(c)(6) |
37 CFR 401.14(f)(4) |
|
46 |
Patent Record |
Other Document Upload |
|
|
|
47 |
Patent Record |
Patent Requests – Request Type |
|
37 CFR 401.14(c)(5) |
|
|
Patent Record |
Requests – Assigning To |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Patent Record |
Requests – Inventor Name |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Patent Record |
Requests – Inventor’s Organization Code |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Patent Record |
Requests – Third Party Name |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Patent Record |
Requests – Third Party Organization Code |
35 USC 202(c)(7) |
37 CFR 401.14(k)(1) |
|
|
Patent Record |
Requests – Transfer to Organization |
|
|
|
48 |
Patent Record |
Patent Requests – SupportDocument |
|
37 CFR 401.14(c)(5) |
|
49 |
Patent Record |
Patent Request – Request Reasons/Comments |
|
37 CFR 401.14(c)(5) |
|
50 |
Patent Record |
Patent Explanatory Notes |
|
|
|
51 |
Utilization Report |
Reporting Year* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
52 |
Utilization Report |
Indicate the latest stage of development of any product arising from this invention, according to the following categories* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
53 |
Utilization Report |
If any product arising from this invention has reached the market, what was the calendar year of the first commercial sale* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
54 |
Utilization Report |
In the designated reporting period, what was the total income received as a result of license or option agreements? Do not include specific patent costs reimbursement. * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
55 |
Utilization Report |
Did the grantee organization/contractor or any of the exclusive licensees request a waiver of the U.S. manufacturing requirements in the designated reporting period? * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
56 |
Utilization Report |
If yes, how many such waivers were obtained? * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
57 |
Utilization Report |
Commercial Product Name (of FDA-Approved Product) * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
58 |
Utilization Report |
FDA Approved Number* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
59 |
Utilization Report |
FDA Approval Type* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
60 |
Utilization Report |
Public (Yes/No)* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
61 |
Utilization Report |
In the designated reporting period, how many exclusive licenses and/or Options are active? * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
62 |
Utilization Report |
In the designated reporting period, how many non-exclusive licenses and/or options are active? * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
63 |
Utilization Report |
How many licenses and/or options of any type to small businesses (<500 employees are active in the designated reporting period? * |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
64 |
Utilization Report |
Approx. Number of US-based Jobs Created Because of Commercialization Efforts During Reporting Period+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
65 |
Utilization Report |
Number of new US-based Companies Created from Commercialization Efforts During Reporting Period+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
66 |
Utilization Report |
Unique Commercial Products made (with NAICS code if applicable) + |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
67 |
Utilization Report |
Manufacturing Country+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
|
Utilization Report |
Manufacturing State |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
|
Utilization Report |
First Date of Manufacturing |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
|
Utilization Report |
Manufacturing Type |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
|
Utilization Report |
Manufacturing Product Quantity |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
69 |
Utilization Report |
Describe how development complies with US manufacturing requirements (e.g., U.S. Preference, a U.S. Competitive Clause, U.S. Manufacturing Plan, etc.) + |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
* Information only required for NIH and/or DOE funded technologies
+ Information only required for DOE funded technologies
The information detailed above will be collected from recipients of federal funding with resulting inventions, including universities, research institutions, hospitals, non-profit organizations, for-profit businesses, etc. Information will also be collected from individual inventors who, with federal agency approval in accordance with the Bayh-Dole Act and associated regulations, had patent rights assigned back to them by the organization that received federal funding. Although there may be rare occasions where information may need to be collected via email, by phone, or by paper mail, the information will be primarily collected via the iEdison website to allow for an easily centralized location for reporting information to all of the agencies who have registered with iEdison. The information will be provided to all federal agencies who have registered iEdison accounts. Agencies registered with iEdison will have full read access to records to which they are associated as a funding agency (the primary funding agency will have edit access).
Because of the volume of information, the implication of publication on the availability of patent protection, and the legislative and regulatory timeline requirements, the information provided will be reported and used constantly and on an on-going basis.
Overall, the information collected is either required by the Bayh-Dole Act and its regulations or they help advance, track compliance and/or measure impact related to the Act’s purpose and objectives. Agreement to provide the information is essentially a requirement to receive the benefit of federal research dollars. The information is used by federal agencies in the following ways:
To ensure that federal agencies are made of aware of the inventions and patents, and the utilization thereof, associated with its funding programs and to which the government has certain rights;
To tie inventions and patents to their associated federal funding programs;
To allow inventions resulting from federal research the opportunity to be protected and commercialized either by the Contractor or (if the Contractor does not pursue or continue to pursue protection) the government;
To track compliance with the Bayh-Dole Act and its implementing regulations;
To track ROI from federal research funding in a number of ways, including inventions, patents, revenue, licenses, products, jobs, etc.
In general, we only anticipate that limited data derived from the information entered into the system will be made public, specifically the number of subject inventions, patent applications, issued patents, requests, and conveyances to the government. However, the specifics of the information in general is not anticipated to the released publicly. Certain information is subject to confidentiality requirements (see answer to question 10), but might be released to individuals under a FOIA request if certain requirements are met. The exception to this statement is NIH-funded FDA-approved products. These products are routinely published on a public website by the NIH to inform the public which FDA-approved products were developed with NIH funding.
3. Describe whether, and to what extent, the collection of information involves the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses, and the basis for the decision for adopting this means of collection. Also describe any consideration of using information technology to reduce burden.
Information will be primarily entered electronically via NIST’s iEdison website. NIST has also implemented a number of technological features to minimize the burden on users. NIST has made an Application Programming Interface (API) available for users to connect the system to their own internal intellectual property database. The API allows certain information to be reported automatically from the Contractor’s database into the iEdison system without having to manually enter the information via the iEdison website. NIST is also utilizing drag and drop technology to allow for easier and more efficient upload of documentation into the iEdison records. Additionally, when associated patent records are generated, certain information is auto-populated from existing records. If this information is not accurate, the Contractor can correct the information, but the auto-population feature saves time for the Contractor by avoiding the manual entry of similar information. Finally, NIST has implemented API integrations with other government websites, such as the USPTO and sam.gov, so that if certain information is available for a patent application (such as the Title, Inventors, Issued Patent Number, and Issued Patent Date) or for a company (such as the Company Name and Address), this information can be auto-populated and/or updated in the iEdison records.
4. Describe efforts to identify duplication. Show specifically why any similar information already available cannot be used or modified for use for the purposes described in Item 2 above.
Pursuant to the regulations and federal funding agreements, each agency that provides federal funding contributing to the conception or first actual reduction to practice of an invention must have inventions, associated patents, and other information reported to them. Utilizing iEdison, if multiple funding agreements supported one invention, each agency and funding agreement would be entered into the single invention record to avoid having to send a separate report to each agency. However, participation by each federal agency in iEdison is not mandatory, so there may be instances where an invention, its associated patents, and other information may need to be reported within iEdison to a participating agency and outside of iEdison to a federal agency (or agencies) that does not participate with iEdison. To limit this reporting duplication, significant effort has been made to register as many funding agencies in iEdison as possible. Currently, more than 30 federal agencies are either enrolled in the current iEdison system or intend to participate in the redesigned iEdison system.
To avoid duplication with the iEdison system itself, the system recognizes if a contractor tries to enter an invention record with the same title as a previously submitted record and notifies that contractor that this could be a duplicate record and they should confirm that this record was not previously entered. Additionally, each patent serial number can only be entered into the system once (across all contractors). If a contractor tries to enter a patent serial number that has already been entered, they are given an error and told that the serial number already exists in the system.
5. If the collection of information impacts small businesses or other small entities, describe any methods used to minimize burden.
Small businesses and entities normally do not have the same volume of information to enter into the database as larger institutions, such as universities. However, we have implemented time-saving features by building in the capabilities discussed in Question 3 above. NIST has programmed portions of the database to auto-populate basic information.
6. Describe the consequence to Federal program or policy activities if the collection is not conducted or is conducted less frequently, as well as any technical or legal obstacles to reducing burden.
If this information is not collected by Federal funding agencies in a timely manner, then the agencies would be out of compliance with requirements under the Bayh-Dole Act (35 USC § 200-212). Additional information not specifically required under the Bayh-Dole Act and its implementing regulations at 37 CFR 401, is allowed as additional information which can be collected under 37 CFR 401.5(f), which permits requiring certain additional information to be entered into grants or contracts terms and conditions, and 401.14(h), which allows agencies to require information related to utilization of inventions up to annually. In addition to being out of compliance, the consequences of not receiving this information in a timely manner include:
Loss of intellectual property rights of interest to the government;
Inability to calculate ROI from federally funded research programs;
Unnecessary government spending as a result of government licensing and paying for rights to inventions in which they already have a government use license.
7. Explain any special circumstances that would cause an information collection to be conducted in a manner: requiring respondents to report information to the agency more often than quarterly; requiring respondents to prepare a written response to a collection of information in fewer than 30 days after receipt of it; requiring respondents to submit more than an original and two copies of any document; requiring respondents to retain records, other than health, medical, government contract; grant-in-aid, or tax records, for more than three years; in connection with a statistical survey, that is not designed to produce valid and reliable results that can be generalized to the universe of study; requiring the use of a statistical data classification that has not been reviewed and approved by OMB; that includes a pledge of confidentiality that is not supported by authority established in statute or regulation, that is not supported by disclosure and data security policies that are consistent with the pledge, or which unnecessarily impedes sharing of data with other agencies for compatible confidential use; or requiring respondents to submit proprietary trade secrets, or other confidential information unless the agency can demonstrate that it has instituted procedures to protect the information's confidentiality to the extent permitted by law.
Respondents required to report information to the agency more often than quarterly: In accordance with the regulation and due to foreign and domestic patent laws that require the filing of patent protection before publication or within a specified timeframe afterward, it is necessary for respondents to notify the federal funding agency of inventions and patent filings on an ongoing basis. As such, respondents will likely be required to report information more than quarterly in order to adhere to the regulations and to ensure that patent applications are filed before they are legally barred from doing so.
Respondents required to submit proprietary information: Because the Bayh-Dole Act and its regulations require the disclosure of inventions that are most often pre-patent application and/or patents that are pre-publication, the information contained therein is inevitably proprietary. However, the iEdison system is built to only provide this information to the federal government and is held in confidence. Pursuant to U.S. law, this information cannot be made public until a reasonable amount of time has passed in which to file a patent. Furthermore, the agencies are not required to produce copies of documents included in patent applications. Finally, in accordance with these laws, the Bayh-Dole regulations specifically exempt these documents from FOIA requests for reasonable time periods and only allow disclosure of this information under certain circumstances. As such, proprietary information obtained is kept confidential.
The remaining scenarios described do not apply.
8. If applicable, provide a copy and identify the date and page number of publication in the Federal Register of the agency's notice, required by 5 CFR 1320.8(d), soliciting comments on the information collection prior to submission to OMB. Summarize public comments received in response to that notice and describe actions taken by the agency in response to these comments. Consultation with representatives of those from whom information is to be obtained or those who must compile records should occur at least once every 3 years - even if the collection of information activity is the same as in prior periods. There may be circumstances that may preclude consultation in a specific situation. These circumstances should be explained.
A 60-day Federal Register Notice soliciting public comment was published on Thursday, May 4, 2023 (Vol. 88, pg. 28516-28517). No comments were received.
A 30-day Federal Register Notice soliciting public comment was published on Thursday, August 24, 2023 (Vol. 88, pg. 57941-57942).
NIST has been discussing these standardized utilization questions with the interagency working group for Bayh-Dole on a monthly basis since December of 2021. This group consists of members from agencies across the federal government. The questions went through several rounds of edits and changes due to agency suggestions as well as Executive Order 14104. The interagency working group continues to discuss these questions as we work to create a guidance document to help users know how to answer the utilization questions.
9. Explain any decision to provide any payment or gift to respondents, other than remuneration of contractors or grantees.
There are no plans to provide payments or gifts to respondents.
10. Describe any assurance of confidentiality provided to respondents and the basis for the assurance in statute, regulation, or agency policy. If the collection requires a systems of records notice (SORN) or privacy impact assessment (PIA), those should be cited and described here.
Because information submitted by the respondents often contains unpatented technical information, it is of the highest importance that the information is held in confidence. This fact is routinely communicated to the users through the database’s user manual and training. Pursuant to 35 USC 205, the government can withhold information disclosing any invention in which it has an interest for “a reasonable time in order for a patent application to be filed” and is not required to disclose documents which are part of a patent application.
A Privacy Impact Assessment is not currently needed for this system. The information is deemed a Privacy Act System and is covered under the System of Records Notice COMMERCE/DEPT-23: Information Collected Electronically in Connection with Department of Commerce Activities, Events, and Programs.
11. Provide additional justification for any questions of a sensitive nature, such as sexual behavior and attitudes, religious beliefs, and other matters that are commonly considered private. This justification should include the reasons why the agency considers the questions necessary, the specific uses to be made of the information, the explanation to be given to persons from whom the information is requested, and any steps to be taken to obtain their consent.
Collection of gender is possibly a question of a sensitive nature and may be considered private. This field will be voluntarily given by the participant and is not required. NIST wishes to collect this information as we believe it can provide information to understand whether agency programs are achieving equity in program participation, specifically as it relates to the innovation process, and promoting the collection of information that has been shown to raise awareness and promote equity.
12. Provide estimates of the hour burden of the collection of information.
Providing burden estimates for this particular collection is difficult because not all record types (discussed in the answer to question 2 above) and not all fields will be applicable to each case and the frequency of entering information by users varies drastically based on the volume of their federal funding and how often that funding results in inventions. However, in order to most accurately estimate the burden, we have broken the hour burden down by record type (invention, patent, and utilization) and calculated the average number of each type of record which have been recorded in the current iEdison system for the last 5 years (Table 1 below). We then divided the total burden by the current number of Organizations with iEdison accounts (Table 2 below). However, it should be noted that some users, such as a small business, may only need to report 1 technology into iEdison ever, whereas other users, such as large research universities, may need to report hundreds or even thousands of inventions, patents, and utilization reports every year.
Annual Burden
Record Type |
Number of respondents |
Time to complete |
Burden Hours |
Invention Records |
3063 |
75 minutes (5 times /year) |
19,144 hours |
Patent Records |
3063 |
45 minutes (5 times / year) |
11,486 hours |
Utilization Records |
3063 |
25 minutes (30 times / year) |
38, 288 hours |
* Utilization Records are the only record type to undergo a burden change in this revision.
13. Provide an estimate for the total annual cost burden to respondents or record keepers resulting from the collection of information. (Do not include the cost of any hour burden already reflected on the burden worksheet).
There are no capital/start-up or ongoing operation/maintenance costs associated with this information collection.
14. Provide estimates of annualized costs to the Federal government. Also, provide a description of the method used to estimate cost, which should include quantification of hours, operational expenses (such as equipment, overhead, printing, and support staff), and any other expense that would not have been incurred without this collection of information. Agencies may also aggregate cost estimates from Items 12, 13, and 14 in a single table.
Type |
Annual Budget |
OISM Personnel (2 programmers, one data manager) |
$68,000 |
Contractor Support |
$505,000 |
TPO Personnel (1 manager, 1 data manager) |
$400,000 |
Software and Hosting Fees (iEdison.gov domain cost, login.gov service fee, AWS service fee, Salesforce service fee) |
$120.000 |
TOTAL |
$1,705,000 |
15. Explain the reasons for any program changes or adjustments reported on the burden
worksheet.
The Bayh-Dole Act (35 USC 18) and its implementing regulations (37 CFR 401) allow agencies to ask Contractors for periodic reports on the utilization of a subject invention or on efforts at obtaining such utilization. Under the regulations, these reports shall include “information regarding the status of development, date of first commercial sale or use, gross royalties received by the contractor, and such other data and information as the agency may reasonably specify. These new questions are deemed reasonable to request for a number of reasons. The new questions include a follow-up question to provide details when an invention is not licensed or commercialized to ensure that practical application is being timely achieved and additional information regarding product manufacturing to ensure that contractors, assignees, and licensees are compliant with any domestic manufacturing requirements.
Executive Order 14104 directs funding agencies to require Contractors to annually report to the funding agency the names of licensees and manufacturing locations of subject inventions (EO 14104, Section 4(c)). Executive Order 13985 directs agencies to assess whether their programs perpetuate systemic barriers to opportunities and benefits. In order to conduct these assessments, data is needed. The addition of the gender data field is a first step for agencies to be able to analyze participation and disparities by gender in the federally funded innovation process.
Additionally, under the regulations Contractors are required to identify inventors when reporting subject inventions to the funding agency(ies). Gender disparity in the innovation process has been of particular interest over the last several years. This amendment adds a gender data field to inventor information so that contractors and agencies can track participation by gender in inventing, patenting, and licensing and identify if there are any disparities by gender.
The table below details the information/data fields being requested as well as the statute or regulation(s) authorizing the collection of this information and the needs or uses for collection of this piece of information. The information will be collected in one of three major record categories within iEdison: Invention, Patent, or Utilization Records. Some of the data collected are questions already being asked by the current iEdison system, though some questions have been amended and several questions have been added to provide additional data to the funding agencies on the impact of their research programs and to comply with EOs 14104 and 13985. It should be noted that because the iEdison system is used by multiple agencies, the needs/uses listed represent the needs/uses for all agency iEdison users. If only certain agencies use or requested a particular piece of information, that is indicated within the chart. Because most of the information is not made public, but the Contractors who provide the information can use the iEdison database for their own reporting/tracking purposes, the Contractors own uses of the information are also included in the table below.
Item No. |
Record Type where Requirement is Locate |
Requirement |
Statute |
Regulation |
Needs/Uses |
1 |
Invention Record |
Inventor Gender ‡
|
|
|
|
2 |
Utilization Report |
Utilization Report (UR) Year |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
3 |
Utilization Report |
Please indicate the latest stage of development of any product arising from this invention, according to the following categories: Not Licensed or Commercialized; Licensed; Commercialized |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
4 |
Utilization Report |
What are your current commercialization plans for this invention? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
5 |
Utilization Report |
In the designated reporting period, how many exclusive licenses and/or options are or were active? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
6 |
Utilization Report |
Name of each exclusive licensee |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
7 |
Utilization Report |
In the designated reporting period, how many non-exclusive licenses and/or options are or were active? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
8 |
Utilization Report |
Name of each non-exclusive licensee |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
9 |
Utilization Report |
In the designated reporting period, how many licenses and/or options of any type to small businesses (as defined by relevant SBA regulations) are or were active? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
10 |
Utilization Report |
In the designated reporting period, what was the total gross income received as a result of license or option agreements? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
11 |
Utilization Report |
Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing requirements (e.g. U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
12 |
Utilization Report |
In the designated reporting period do all grants to any person of the exclusive right to use or sell the subject invention in the United States require that any products embodying the subject invention or produced through the use of the subject invention will be manufactured substantially in the United States as required by 35 U.S.C. 204? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
13 |
Utilization Report |
In the designated reporting period are all products embodying the subject invention or produced through the use of the subject invention manufactured substantially in the United States for all grants to any person of the exclusive right to use or sell the subject invention in the United States as required by 35 U.S.C. 204? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
14 |
Utilization Report |
In the designated reporting period, do all licenses include a requirement that any products embodying the subject invention or produced through the use of the subject invention will be manufactured substantially in the United States (including manufacturing requirements other than 35 U.S.C. 204)? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
15 |
Utilization Report |
In the designated reporting period, are all products embodying the subject invention or produced through the use of the subject invention manufactured substantially in the United States(including manufacturing requirements other than 35 U.S.C. 204)? |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
16 |
Utilization Report |
What was the calendar year of the first commercial sale? (YYYY) |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
17 |
Utilization Report |
Product Name (for products made through the use of or embodying the subject invention) |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
18 |
Utilization Report |
Name of manufacture(s) |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
19 |
Utilization Report |
Manufacturing Country |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
20 |
Utilization Report |
Manufacturing State (if Manufacturing Country is the United States) |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
21 |
Utilization Report |
Notes |
|
|
|
22 |
Utilization Report |
Commercial Product Name of Any FDA-Approved Product Utilizing Invention* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
23 |
Utilization Report |
FDA Approval Number* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
24 |
Utilization Report |
FDA Approval Type* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
25 |
Utilization Report |
Selection to Make FDA Product Information Public* |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
26 |
Utilization Report |
Approx. Number of US-based Jobs Created Because of Commercialization Efforts During Reporting Period+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
27 |
Utilization Report |
Number of new US-based Companies Created from Commercialization Efforts During Reporting Period+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
28 |
Utilization Report |
Unique Commercial Products made (with NAICS code if applicable) + |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
29 |
Utilization Report |
Number of Each Commercial Product Made at Each Location+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
|
30 |
Utilization Report |
How Development Complies with US Manufacturing Requirement+ |
35 USC 202(c)(5) |
37 CFR 401.14(h) |
16. For collections of information whose results will be published, outline plans for tabulation and publication. Address any complex analytical techniques that will be used. Provide the time schedule for the entire project, including beginning and ending dates of the collection of information, completion of report, publication dates, and other actions.
There are no in-depth statistical analyses being conducted at this time and no plans for publication of in-depth statistical data.
17. If seeking approval to not display the expiration date for OMB approval of the information collection, explain the reasons that display would be inappropriate.
The expiration date will be clearly displayed with the OMB Control Number.
18. Explain each exception to the topics of the certification statement identified in “Certification or Paperwork Reduction Act Submissions.”
There will be no exceptions to the certification statement and NIST certifies compliance with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Reinhart, Liz (Fed) |
File Modified | 0000-00-00 |
File Created | 2023-08-25 |